BOONE WILFORD: Open Payments
NPI 1487044962 · MOUNTAIN HOME, AR. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$273 in 14 payments from 10 companies in 2025. Trend: 2023 $20 · 2024 $193 · 2025 $273
Food & beverage: $273
| Company | Payments | Amount |
|---|---|---|
| Regeneron Healthcare Solutions, Inc. | 1 | $53 |
| AstraZeneca Pharmaceuticals LP | 3 | $49 |
| Celgene Corporation | 3 | $45 |
| Bayer Healthcare Pharmaceuticals Inc. | 1 | $26 |
| Iovance Biotherapeutics, Inc. | 1 | $20 |
| Novartis Pharmaceuticals Corporation | 1 | $20 |
| E.R. Squibb & Sons, L.L.C. | 1 | $17 |
| Karyopharm Therapeutics Inc. | 1 | $15 |
| Merck Sharp & Dohme LLC | 1 | $14 |
| ABBVIE INC. | 1 | $14 |
Products named: LIBTAYO, ENHERTU, REBLOZYL, Nubeqa, Amtagvi, KISQALI, OPDIVO, XPOVIO.
Industry payments across AR — which companies pay providers there.
